Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China

OBJECTIVE: To investigate the curative and adverse effects (AEs) of additional use of nimotuzumab combined with induction chemotherapy and concurrent chemoradiotherapy in unresectable locoregionally advanced hypopharyngeal carcinoma. PATIENTS AND METHODS: We retrospectively evaluated 36 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xin, Xuan, Ying, Wu, Rong, Gao, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227783/
https://www.ncbi.nlm.nih.gov/pubmed/32494195
http://dx.doi.org/10.2147/CMAR.S248392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227783/
https://www.ncbi.nlm.nih.gov/pubmed/32494195
http://dx.doi.org/10.2147/CMAR.S248392

Ejemplares similares